Mealey's (September 23, 2016, 3:23 PM EDT) -- Thirty-five states and the District of Columbia on Sept. 22 announced that they filed an antitrust lawsuit against the makers of Suboxone, alleging that the manufacturers engaged in “product hopping” to block generic versions of the drug from coming on the market....